Real-time enrollment status for this rsv clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 2:41 PM UTC
| NCT Number | NCT06866405 |
| Recruiting Status | Recruiting |
| Condition | RSV |
| Phase | PHASE3 |
| Target Enrollment | 550 participants |
| Active Locations | 81 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | October 14, 2026 (3 days ago) |
As of October 17, 2026: Clinical trial NCT06866405 is currently recruiting participants. This phase3 study for rsv is actively seeking new participants at 81 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06866405 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 81 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06866405 was last updated 3 days ago (October 14, 2026). HelloStudys verifies this status automatically.